![](/wp-content/themes/yootheme/cache/b1/Maryland-b1f0fbe3.jpeg)
Local Cdiff information for Maryland
Maryland
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Maryland.
Local Cdiff information for Maryland
Maryland
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Maryland.
![](/wp-content/themes/yootheme/cache/b1/Maryland-b1f0fbe3.jpeg)
Providers
Dr. Mark Davis, ND
IBD Specialty Center
2339 Deckman Lane
Silver Spring, 20906
240-507-5110
FMT Provider: Yes
Dr. Maria M. Oliva-Hemker, MD
Director, Division of Pediatric Gastroenterology, Hepatology & Nutrition
Johns Hopkins Pediatrics
200 N Wolfe Street
Baltimore, 21287
410-955-8765
FMT Provider: Yes
Dr. Sudhir Dutta, MD
Division Head of Gastroenterology
Sinai Gastroenterology Associates at Sinai
2401 W Belvedere Ave
Suite 305
Baltimore, 21215
(410) 601-5392
FMT Provider: Yes
Dr. Joshua S. Forman, MD
University of Maryland St. Joseph Medical Center
7505 Osler Drive
Suite 502
Towson, 21204
(410) 296-4210
FMT Provider: Yes
Regulation
C. diff Infections
Total Reported Cases: 1491
Hospital Onset: 1491
Community Onset: Not reported
Related Deaths: Not reported
Available Reports
State Reporting Laws
Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
State Contact
Katherine Richards, MPH
Healthcare-Associated Infections Program Coordinator
Maryland Department of Health and Mental Hygiene
Office of Infectious Disease Epidemiology and Outbreak Response, Prevention and Health Promotion Administration
201 West Preston Street, 3rd Floor
Baltimore, 21201
(410) 767-3543
(410) 669-4215
CLINICAL TRIALS
Animal-Assisted Visitation Program Chlorhexidine Trial
Official Title: Clinical Trial of a Disinfectant Intervention in Therapy Dogs to Combat Hospital-associated Pathogens and Promote Sustainability of Animal-Assisted Visitation Programs
Trial No. NCT04171817
Type: Interventional
Recruitment: Not yet recruiting
Sponsor: Johns Hopkins Bloomberg School of Public Health
Contact: Meghan F Davis, DVM PhD
410-614-8283
Gender: All
Age: 3 Years to 17 Years
FMT National Registry
Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
Gender: All
Age: All ages
OpTION
Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
Gender: All
Age: 18 Years and older
RESTORATiVE303
Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.
AZD5148
Official Title: A Phase I Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults
Trial No. NCT06469151
Type: Interventional
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
Trial No. NCT06469151
Type: Interventional
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
Gender: All
Age: 18 yeras to 65 years